MTMaxime Tijskens

Maxime Tijskens

*This is an algorithmically generated author record based on publicly available information.

Maxime Tijskens has a total of 45 co-authors. Here are the top co-authors by number of shared publications:

  • Yves De Greef

    Department of Cardiology ZAS Middelheim Antwerp Antwerp Belgium

    5 shared publications
  • Bruno Schwagten

    Department of Cardiology ZAS Heart Centre Middelheim Antwerp Belgium

    4 shared publications
  • Juan-Pablo Abugattas

    CHU UCL Namur, Site Sainte‐Elisabeth Namur Belgium

    4 shared publications
  • Michael Wolf

    Department of Cardiology ZAS Heart Centre Middelheim Antwerp Belgium

    4 shared publications
  • Yves De Greef

    Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel—Vrije Universiteit Brussel, European Reference Networks Guard-Heart , Laarbeeklaan 101, 1090 Brussels

    4 shared publications
  • Andrea Sarkozy

    Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, European Reference Networks Guard-Heart , Brussels

    3 shared publications

Latest Publications

  • Open Access

    The Finding of Posterior Wall Low-Voltage Zones During Cryoballoon Pulmonary Vein Isolation Facilitated by Periprocedural Electroanatomical Mapping Is Associated with a Worse Ablation Outcome

    by Maxime Tijskens, Benjamin De Becker, Michael Wolf, Bruno Schwagten, Yves De Greef

    Background: The presence of left atrial fibrosis is a marker of advanced remodeling and is associated with a worse outcome after pulmonary vein isolation (PVI). Conventional fluoroscopy-only cryoballoon ablation (CBA) lacks this prognostic information. The addition of electroanatomical mapping (EAM) using the inner lumen spiral catheter allows accurate voltage assessment of the left atrial posterior wall. However, the value of the finding of posterior wall low-voltage zones (pwLVZs) is unknown. Purpose: To study the value of left atrial voltage maps during CBA by comparing clinical and procedural characteristics and clinical outcome between patients with and without pwLVZs. Methods: A cohort of 250 consecutive patients who underwent index CBA for atrial fibrillation was analyzed. All patients underwent pre- and post-procedural EAM using the AchieveTM catheter and EnSiteTM mapping system. The presence of LVZs was evaluated at the postprocedural voltage map of the posterior wall. Clinical success was defined as freedom from documented AF or atrial tachycardia (AT) >30 s after 1 year. Results: PwLVZs were found in 41/250 (16.4%) of patients. Patients with pwLVZs were older (69.3 ± 8.5 vs. 64.2 ± 10.4; p = 0.003), more frequently female (63.4% vs. 32.5%; p < 0.001) and had higher CHA2DS2-VASc scores (3.0 ± 1.6 vs. 2.0 ± 1.5; p < 0.001). The incidence of obesity (31.7% vs. 25.8%; p = 0.048), structural heart disease (35.5% vs. 17.4%; p = 0.021) and persistent AF (68.3% vs. 43.8%; p = 0.004) was higher in the pwLVZs group. Kaplan–Meier analysis of clinical outcome showed a higher recurrence rate in the pwLVZs group. The finding of pwLVZs was a predictor of atrial arrhythmia recurrence during follow-up (HR 2.583; 95%CI: 1.334–5.002; p = 0.005). Conclusions: In CBA facilitated by integrated EAM, pwLVZ was associated with older age, female sex, higher CHADS-VASc scores, obesity, structural heart disease and persistent AF. The finding of pwLVZs is predictive of a worse clinical outcome.

  • A Prospective Study of a Novel Pocket Compression Device to Reduce Pocket Hematoma After Cardiac Implantable Electronic Device Implantation in a High Bleeding Risk Population

    by M. Tijskens, K. De Schouwer, M. Wolf, Y. De Greef, B. Schwagten

    Background: Pocket hematoma (PH) is one of the most common complications after cardiovascular implantable electronic device (CIED) implantation resulting in an up to 9 times higher risk for CIED infections. Different preventive strategies have been proposed with mixed results. Current standard of care consists of preventive elastic adhesive tape leaving 2 major disadvantages: unpredictable pressure on the pocket and inability to visually assess the pocket with the bandage applied. Aim: To evaluate the safety and effectiveness of a novel pocket compression device in patients undergoing CIED implantation in a high bleeding population. Material and Methods: This randomized controlled trial included 32 patients in the study group (pocket compression device) and 33 in the control group (elastic adhesive tape). The studied pocket compression device contains an inflatable and transparent compartment to modify the degree of pocket compression facilitating pocket evaluation. The primary outcome was the incidence of various grades of PH. The secondary outcomes comprised the incidence of pressure lesion, pain score (0‐10) and endocarditis during follow‐up. Results: There were no clinical or procedural differences between groups (age 78.01 ± 9.71, heart failure 53.8%, kidney failure 20.0% and antithrombotic drug therapy 49.2%). There were significantly less pocket hematomas in the study group (1/32 (3.1%) vs 20/33 (60.6%), p < 0.001). Most pocket hematomas were grade I for which watchful waiting was applied (1/32 (3.1%) vs 17/33 (51.6%), p < 0.001). Grade II and grade III PH only occurred in the control group (respectively 1/33 and 2/33) resulting in hospitalization prolongation and longer interruption of antithrombotic drugs > 24 h. Two control patients eventually received the study device to control PH. None underwent reoperation. Pressure lesions did not occur. Patients in the study group had lower pain scores at application (0.75 ± 1.12 vs 1.80 ± 1.38, p = 0.009), after 2 h (0.81 ± 1.36 vs 1.94 ± 1.50, p = 0.002) and the next day (0.38 ± 0.91 vs 1.06 ± 1.634, p = 0.042). None of the patients experienced endocarditis during mean follow‐up of 1 year. Conclusion: The use of a pocket compression device in patients undergoing CIED implantation in a high bleeding population leads to less PH and postoperative pain in comparison to conventional elastic adhesive tape. This is especially important in an era where safety of device implantations is paramount.


  • Adding Non‐Occlusive Cryoballoon Ablation in Case of Ostial‐Level Pulmonary Vein Isolation or Carina Sparing Does Not Improve 1‐Year Outcome After Cryoballoon Ablation (the NOCA‐AF Study)

    by A. Strazdas, M. Tijskens, J. P. Abugattas, M. Wolf, B. Schwagten, Y. De Greef

    Introduction: Fixed‐diameter cryoballoon ablation (CBA) can yield suboptimal ostial‐level pulmonary vein isolation (PVI) and spare arrhythmogenic sites like the carina. The addition of non‐occlusive cryoballoon ablation (NOCA) could overcome this limitation of CBA. We aimed to assess the need and effectiveness of NOCA and its impact on clinical outcomes.Methods and Results: One hundred AF patients (66 ± 10 years, 40 females) were prospectively randomized to CBA (Control group, n = 50) or CBA + NOCA if needed (Study group, n = 50). Ostial‐level PVI and carina sparing was assessed by electroanatomic left atrial (LA) voltage mapping after CBA. Endpoint was documented AF/AFL/AT ( > 30 s) at 12 months, with Holters at 6 and 12 months. After CBA, ostial PVI level was seen in 110 out of 392 veins (28%), with predominance of the left superior PV and carina sparing in 11 (11%) left PVs and 16 (16%) right PVs. Overall, voltage mapping displayed a potential NOCA need in 68 (68%) patients. Spatially, for both PV sides, preferential ostial‐level PVI segments were situated at the posterior wall. NOCA was added in 38 (76%) study patients, confirmed effective in all by voltage remapping. At 1 year, AF/AFL/AT recurrence occurred in 12 (24%) Study and 6 (12%) control patients (p = 0.121).Conclusions: Ostial‐level PVI and carina sparing occurs in a substantial amount of patients treated by CBA. Although NOCA proved effective in extending the lesion size to antral‐level PVI or carina ablation, adding NOCA did not improve 1‐year clinical outcome.


  • Recurrence of Atrial Fibrillation After Cryoballoon Ablation in Women Is Less Pulmonary Vein Mediated as Compared to Men: Lessons From Repeat Ablation Procedures

    by Maxime Tijskens, Juan Pablo Abugattas, Michael Wolf, Bruno Schwagten, Yves De Greef

    Background: Data on sex‐related outcomes of pulmonary vein isolation (PVI) of cryoballoon ablation (CBA) in atrial fibrillation (AF) are sparse.Aim: To compare sex‐differences in PV reconnection, strategy and outcome of repeat ablations after CBA.Methods: Repeat procedures were performed using radiofrequency ablation guided by 3D mapping. PV reconnection characteristics were compared in 229 patients (77 (33.6%) females). In durable PVI patients, we compared left atrial voltage maps, ablation strategy and 1‐year outcome. Clinical success was defined as freedom of documented AF or atrial tachycardia (AT) > 30 s.Results: Female patients had a lower overall number of PV reconnections (0.8 ± 0.9 vs 1.2 ± 1.0, p < 0.001) driven by less reconnected left PVs: 13/77 (16.9%) vs 51/152 (33,6%), p = 0.008 and 7/77 (9.1%) vs 39/152 (25.7%), p = 0.003 for LSPV and LIPV, respectively. Durable PVI was more frequent in women (34/77 (44.1%) vs 37/152 (24.4%), p = 0.001). Female sex was the only independent predictor for durable PVI (HR = 2.003; 95% CI 1.090–3.682; p = 0.025). In durable PVI patients, substrate ablation was more frequently performed in women (21/35 (60%) vs 13/35 (37.1%), p = 0.044), mainly targeting the higher prevalent atrial low‐voltage zones (21/35 (60.0%) vs 12/36 (33.3%), p = 0.017). At 1 year, recurrence of AF/AT did not differ between sexes: 6/35 (17.1%) versus 8/35 (22.9%), p = 0.591.Conclusions: The higher persistence of durable PVI in women points to a sex difference in AF recurrence driver after CBA. In durable PVI patients, a higher prevalence of low‐voltage regions results in more substrate ablation in women. Despite sex differences in ablation strategy, 1‐year outcome was similar.


  • Open Access

    Recurrence of atrial fibrillation after cryoballoon ablation in women is less pulmonary vein mediated as compared to men: lessons from repeat ablation procedures

    by Maxime Tijskens, Juan Pablo Abugattas, Michael Wolf, Bruno Schwagten, Yves De Greef

    Background: Data on sex-related outcomes of pulmonary vein isolation (PVI) of cryoballoon ablation (CBA) in atrial fibrillation (AF) are sparse. Aim : To compare sex-differences in PV reconnection, strategy and outcome of repeat ablations after CBA. Methods: Repeat procedures were performed using radiofrequency ablation guided by 3D mapping. PV reconnection characteristics were compared in 229 patients (77 (33.6%) females). In durable PVI patients, we compared left atrial voltage maps, ablation strategy and 1-year outcome. Clinical success was defined as freedom of documented AF or atrial tachycardia (AT) >30s. Results: Female patients had a lower overall number of PV reconnections (0.8±0.9 vs 1.2±1.0, PConclusions: The higher persistence of durable PVI in women points to a sex difference in AF recurrence driver after CBA. In durable PVI patients, a higher prevalence of low-voltage regions results in more substrate ablation in women. Despite sex differences in ablation strategy, 1-year outcome was similar.

  • Open Access

    Cryoballoon pulmonary vein isolation facilitated by integrated electroanatomical mapping for paroxysmal atrial fibrillation in a patient with Kartagener’s syndrome: a case report

    by Maxime Tijskens, Michael Wolf, Bruno Schwagten, Yves De Greef

    We describe the first case of cryoballoon (CB) pulmonary vein isolation (PVI) facilitated by perioperative electroanatomical mapping (EAM) in a patient with dextrocardia due to Kartagener’s syndrome and highly symptomatic paroxysmal atrial fibrillation. Current case report highlights the different advantages of the addition of EAM to CB ablation for AF. This approach is feasible strategy for rhythm control in patients with atrial fibrillation and Kartagener’s syndrome for which medication can be contra-indicated.

  • Open Access

    Adding 3D electroanatomical mapping to cryoballoon pulmonary vein isolation improves pulmonary vein isolation durability at repeat ablation procedure

    by M Tijskens, J P Abugattas, M Wolf, B Schwagten, Y De Greef

    Objectives: The addition of pre- and post-ablation electroanatomical mapping with the Achieve catheter and EnSite mapping system has shown to improve acute pulmonary vein isolation (PVI) rate of cryoballoon ablation (CBA). Recently, our group also demonstrated an improvement in 1-year outcome. Current study aimed to investigate the impact on PVI durability as seen during repeat ablation procedure. Methods: 400 patients were compared in a propensity-matched analysis between CT- and Achieve catheter guided CBA (Control group; N=200) and Achieve catheter guided CBA with additional EnSite voltage maps performed pre- and post-CBA (Mapping group; N=200). Matching parameters were age, AF type and CHADS-VASc score. In patients undergoing repeat procedure, PV status was evaluated using CARTO mapping system. Results: Baseline characteristics did not differ between both groups (Persistent AF: 47,5% vs. 46,5%, P=0,841; diagnosis-to-ablation time: 28,1±15,1 vs. 33,2±41,7months, P=0,107). The mapping group had a shorter follow-up time (25,6±7,2 vs. 50,3±3,3months, P<0,001). Repeat ablation was performed in 20 patients in the mapping group and 70 patients in the control group. At repeat, the proportion of patients with persistent complete PVI was higher in the mapping group (14/20(70.0%) vs 23/70(32,9%), P=0,030). Interestingly, less reconnections of the right inferior PV were seen in the mapping group (10,0% vs. 34,3%, P=0,035). There was no difference in reconnection rate of other PVs. Conclusions: The addition of electro-anatomical EnSite mapping to the Achieve catheter improves PVI durability as seen during repeat ablation, mainly at the level of the right inferior PV. This finding might explain the improvement in 1-year outcome of this approach.

  • Open Access

    Adding Electroanatomical Mapping to Cryoballoon Pulmonary Vein Isolation Improves 1-Year Clinical Outcome and Durability of Pulmonary Vein Isolation: A Propensity Score-Matched Analysis

    by Maxime Tijskens, Juan Pablo Abugattas, Hendrik Thoen, Antanas Strazdas, Bruno Schwagten, Michael Wolf, Yves De Greef

    Background: Adding electroanatomical left atrial (LA) voltage mapping to cryoballoon ablation (CBA) improves validation of acute pulmonary vein isolation (PVI). Aims: To determine whether the addition of mapping can improve outcome and PVI durability. Methods: One-year outcome and PV reconnection (PVR) rate at first repeat ablation were studied in 400 AF patients in a propensity-matched analysis (age, AF type, CHA2DS2-VASc score) between Achieve catheter-guided CBA with additional EnSite LA voltage maps performed pre- and post-CBA (mapping group; N = 200) and CT- and Achieve catheter-guided CBA (control group; N = 200). Clinical success was defined as freedom of documented AF or atrial tachycardia (AT) > 30 s. PV reconnection patterns were characterized in repeat ablations. Results: At 1 year, 77 (19.25%) patients had recurrence of AF/AT, significantly lower than in the mapping group: 21 (10.5%) vs. 56 (28%), p < 0.001. Procedure time was shorter (72.2 ± 25.4 vs. 78.2 ± 29.3 min, p = 0.034) and radiation exposure lower (4465.0 ± 3454.6 Gy.cm2 vs. 5940.5 ± 4290.5 Gy.cm2, p = 0.037). Use of mapping was protective towards AF/AT recurrence (HR = 0.348; 95% CI 0.210–0.579; p < 0.001), independent of persistent AF type (HR = 1.723; 95% CI 1.034–2.872; p = 0.037), and LA diameter (HR = 1.055; 95% CI 1.015–1.096; p = 0.006). At repeat ablation (N = 90), persistent complete PVI was seen in 14/20 (70.0%) versus 23/70 (32.9%) in the mapping and conventional group, respectively (p = 0.03). Reconnection rate of the right inferior PV was lower with mapping (10.0% vs. 34,3%, p = 0.035). Conclusions: Adding electroanatomical LA voltage mapping to CBA improves 1-year clinical outcome and lowers both procedure time and radiation exposure. At repeat, use of mapping increases complete persistent PVI mainly by improving PVI durability of the RIPV.